Observational studyPloS one2024

Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter prospective observational study.

Machiko Kai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.